Volume | 12,037 |
|
|||||
News | - | ||||||
Day High | 43.16 | Low High |
|||||
Day Low | 43.16 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Crinetics Pharmaceuticals Inc | CRNX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
43.16 | 43.16 | 43.16 | 44.00 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
19 | 12,037 | US$ 43.16 | US$ 519,517 | - | 15.76 - 49.5799 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
08:30:16 | 1 | US$ 43.1455 | USD |
Crinetics Pharmaceuticals (CRNX) Options Flow Summary
Crinetics Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.06B | 69.60M | - | 4.01M | -214.53M | -3.08 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Crinetics Pharmaceuticals News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRNX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 43.57 | 45.26 | 41.05 | 43.23 | 583,808 | -0.41 | -0.94% |
1 Month | 45.87 | 49.5799 | 41.05 | 45.41 | 759,029 | -2.71 | -5.91% |
3 Months | 37.72 | 49.5799 | 35.79 | 42.84 | 815,542 | 5.44 | 14.42% |
6 Months | 28.25 | 49.5799 | 25.75 | 37.90 | 819,626 | 14.91 | 52.78% |
1 Year | 19.48 | 49.5799 | 15.76 | 30.75 | 914,693 | 23.68 | 121.56% |
3 Years | 17.46 | 49.5799 | 15.23 | 26.57 | 495,678 | 25.70 | 147.19% |
5 Years | 25.88 | 49.5799 | 10.63 | 25.25 | 341,259 | 17.28 | 66.77% |
Crinetics Pharmaceuticals Description
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. |